THCV - For Weight Loss and Metabolic Syndrome: Next Big Cannabinoid
Dr. Gregory L Smith, MD, MPH, Green Mountain Health Alliance
I will discuss the similarities and signfiicant differences of THCV (tetrahydrocannabivarin) and THC and CBD. I will then discuss the pertinent recent research showing efficacy from using THCV for weight loss, blood glucose and blood lipid control through the ECS. Then provide guidance for dosing THCV for these conditions.
Dr. Gregory Smith earned his medical degree from Rush Medical School in Chicago, and a Masters of Public Health from Harvard University. He completed residency training in Preventive Medicine at Walter Reed Army Medical Center. Since getting out of the US Army as a Major, Dr. Smith has been in primary care practice in California, Georgia and Florida for the past 30 years. He first trained on use of medical cannabis in California in 2000. He has had extensive experience and education in the field of cannabinoid medications. Dr. Smith is an avid writer, having published over a dozen peer reviewed medical publications, two medical textbooks, and a novel called "Malpractice.” His most recent textbook, is entitled Medical Cannabis: Basic Science and Clinical Applications (Aylesbury Press, 2016 – www.AylesburyPress.com). It is a scientifically-based textbook directed at educating medical students and medical professionals on the science and applications of cannabinoid medications. His book for patients and caregivers is called CBD: What You Need to Know (Kindle Press, 2017). He also just recently published THCV (tetrahydrocannabivarin) : Weight Loss, Blood Sugar and Blood Lipid Control (Kindle Press, 2018). He is the author of a chapter in the prestigious CRC Press textbook, Antioxidant Nutraceuticals – Preventive and Healthcare Applications (CRC Press,2018) Dr. Smith has been working with medical cannabis-related issues full-time for the past 5 years. He is a prolific writer on the topic of clinical applications of medical cannabis with many publications and video training courses. He is and Scientific Advisor to MediCann (Denmark), Callitas Therapeutics (US) and Green Mountain Health Alliance (Canada).